Medical Cannabis Certification – Preproposal Statement of Inquiry (CR 101) Filed
On October 9, 2026, the Liquor and Cannabis Board (LCB) took the following action:

200 articles
What’s changing in cannabis law: our editors’ articles, and announcements straight from regulators, courts, governments and companies.
On October 9, 2026, the Liquor and Cannabis Board (LCB) took the following action:

The New York State Office of Cannabis Management (OCM) is reminding cannabinoid hemp retailers of the requirements for cannabinoid hemp beverage products sold in New York State.

The Division of Cannabis Regulation (DCR) is aware of some confusion about testing requirements for ingestible marijuana concentrates. Marijuana products such as Rick Simpson Oil (RSO) and Full Extract Cannabis Oil (FECO) are…

100 Facilities Generally with the Secretary of State and the Joint Committee on Administrative Rules. Before initiating the formal rulemaking process, DHSS proactively gathered public feedback to promote transparency among…

October 1, 2026 – The Cannabis Regulatory Agency (CRA) today issued a final order revoking the adult-use retailer license of Budbridge LLC, doing business as Muha Meds Ypsilanti, and imposing a $251,250 fine for seven…

September 29, 2026 – The Cannabis Regulatory Agency (CRA) has revoked 20 medical marijuana Class C grower licenses held by GP Holdings LLC, doing business as Millie Montana Industries, and imposed a $2 million fine following…

MAR Notice No. 2026-155.2 – Clarify Day-to-Day Operational Control Requirements of Marijuana Businesses

September 25, 2026 – Final licensing denials, non-renewals, administrative formal complaints, and disciplinary actions taken against adult-use/medical licensees in August are now available for review in the Cannabis Regulatory…

Oregon Health Authority (OHA) will not be moving forward with the current psilocybin rulemaking process that would have included increased license fees.

The September 2026 Public Comment Period for Oregon Psilocybin Services proposed rules will close on Monday, September 21st 2026 at 5:00pm (Pacific Time).

9/18/26 – In the interest of public health and safety, Fawn River Cultivation Company LLC (AU P 000460), in coordination with the Michigan Cannabis Regulatory Agency (CRA), is voluntarily recalling the Hash Melts (Green Crack 1G…

September 16, 2026 – The Michigan Cannabis Regulatory Agency (CRA) has announced the closure of Michigan Investment 10 LLC’s adult-use processor license and the revocation of its medical processor license, along with a $2 million…

5g – 5ct. – CHERRY LIMEADE source tag 1A40C0300005E25000004098 produced by CCMRB Processing, LLC, MAN000103. 100(4)(P), DCR may issue a public notice of recall where marijuana product presents a potential threat to health and…

The first of two public hearings on proposed rules will begin tonight at 6:00pm (Pacific Time).

Pursuant to the Administrative Rules, licensees have a continuing duty to provide the Cannabis Regulatory Agency (CRA) with up-to-date contact information and must notify the CRA in writing of any changes to the contact…

JEFFERSON CITY, MO – Today, Missouri’s Division of Cannabis Regulation (DCR) posted the results of the random lottery drawing of microbusiness license applicants.

Today, September 1, 2026, marks the beginning of a new chapter for the Oregon Medical Marijuana Program (OMMP) and the Oregon Psilocybin Services (OPS) section as we merge into the Medical Cannabis & Psilocybin (MCAP) section.

The September 2026 Public Comment Period for Oregon Psilocybin Services proposed rules is now open. The proposed rules include significant increases to all fees and elimination of reduced fees.

JEFFERSON CITY, MO – The Missouri Division of Cannabis Regulation (DCR), in partnership with GF Extraction Lab LLC, issued a marijuana product recall today for marijuana products originating from GF Extraction Lab LLC, MAN000042.

The New York State Cannabis Control Board will hold a public meeting on Thursday, September 3, 2026, at 11:00 a.m. at the CUNY Graduate School of Public Health, 55 West 125th Street, New York, NY 10027.
